According to the Virginia Department of Health, Virginia is not experiencing an outbreak of meningococcal disease, a serious ...

The US FDA has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease.

For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after stopping rituximab.

Bonner said anyone exhibiting symptoms of the disease should make an appointment with Student Health and Wellness for ...

The latest meeting of the U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practi ...

Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza ...

As the Texas measles outbreak grows and HHS head RFK Jr. puts vaccines under new scrutiny, two experts answer questions about the public health tool.

The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr. comes as the U.S. records its first ...